$SPAI
Safe Pro Group Inc Stock $spai

$spai Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224038306 Filed on September 26, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024 Q1
Revenue	$330.8K	$643.0K	$307.7K
YoY Change	102.24%	524.21%
Cost Of Revenue	$196.5K	$458.4K	$180.4K
YoY Change	94.38%	562.16%
Gross Profit	$134.2K	$184.6K	$127.2K
YoY Change	114.96%	446.46%
Gross Profit Margin	40.58%	28.71%	41.35%
Selling, General & Admin	$418.4K	$249.5K	$1.081M
YoY Change	369.33%	162.74%
% of Gross Profit	311.67%	135.15%	849.56%
Research & Development			$85.78K
YoY Change
% of Gross Profit			67.43%
Depreciation & Amortization	$99.58K	$62.38K	$60.68K
YoY Change	66.62%	5.23%
% of Gross Profit	74.18%	33.79%	47.7%
Operating Expenses	$3.676M	$1.307M	$1.212M
YoY Change	396.35%	71.1%
Operating Profit	-$3.542M	-$1.123M	-$1.085M
YoY Change	422.26%	53.74%
Interest Expense		-$92.12K	-$58.97K
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$143.4K	-$92.12K
YoY Change	9055.94%	7903.21%
Pretax Income		-$1.215M	-$1.144M
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	-$3.685M	-$1.215M	-$1.144M
YoY Change	442.15%	66.09%
Net Earnings / Revenue	-1114.25%	-188.95%	-371.81%
Basic Earnings Per Share	-$0.34	-$0.14
Diluted Earnings Per Share	-$0.34	-$0.14	-$0.08
COMMON SHARES
Basic Shares Outstanding	13.68M shares	8.901M shares
Diluted Shares Outstanding	10.78M shares	8.901M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments		$176.0K	$399.6K
YoY Change
Cash & Equivalents	$2.335M	$176.0K
Short-Term Investments
Other Short-Term Assets		$194.5K	$211.2K
YoY Change
Inventory	$375.3K	$364.6K	$402.6K
Prepaid Expenses
Receivables	$221.5K	$41.38K	$72.84K
Other Receivables			$0.00
Total Short-Term Assets	$3.350M	$776.4K	$1.086M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$323.8K	$339.2K	$442.3K
YoY Change
Goodwill	$684.9K	$684.9K
YoY Change
Intangibles	$988.2K	$1.070M
YoY Change
Long-Term Investments
YoY Change
Other Assets		$9.800K	$9.800K
YoY Change
Total Long-Term Assets	$2.127M	$2.242M	$2.079M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$3.350M	$776.4K	$1.086M
Total Long-Term Assets	$2.127M	$2.242M	$2.079M
Total Assets	$5.477M	$3.018M	$3.165M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$233.7K	$227.3K	$155.0K
YoY Change
Accrued Expenses	$244.8K	$224.8K	$582.3K
YoY Change
Deferred Revenue	$70.29K	$77.41K
YoY Change
Short-Term Debt		$0.00	$0.00
YoY Change
Long-Term Debt Due		$741.0K	$578.8K
YoY Change
Total Short-Term Liabilities	$1.049M	$2.279M	$2.139M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt		$146.0K	$146.0K
YoY Change
Other Long-Term Liabilities		$61.69K	$72.96K
YoY Change
Total Long-Term Liabilities	$193.4K	$207.7K	$219.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.049M	$2.279M	$2.139M
Total Long-Term Liabilities	$193.4K	$207.7K	$219.0K
Total Liabilities	$1.243M	$2.487M	$2.358M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$12.87M	-$9.181M
YoY Change
Common Stock	$1.368K	$911.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.234M	$531.4K	$807.3K
YoY Change
Total Liabilities & Shareholders Equity	$5.477M	$3.018M	$3.165M
YoY Change

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$3.685M	-$1.215M	-$1.144M
YoY Change	442.15%	66.09%
Depreciation, Depletion And Amortization	$99.58K	$62.38K	$60.68K
YoY Change	66.62%	5.23%
Cash From Operating Activities		-$591.5K	-$568.0K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures		$223.5K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$223.5K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		591.3K	264.3K
YoY Change
NET CHANGE
Cash From Operating Activities		-591.5K	-568.0K
Cash From Investing Activities		-223.5K
Cash From Financing Activities		591.3K	264.3K
Net Change In Cash		-223.7K	-303.8K
YoY Change
FREE CASH FLOW
Cash From Operating Activities		-$591.5K	-$568.0K
Capital Expenditures		$223.5K
Free Cash Flow		-$815.0K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	SPAI	Increase In Intangible Assets And Equity For Asset Acquisition IncreaseInIntangibleAssetsAndEquityForAssetAcquisition		usd
	SPAI	Increase In Debt Discount And Additional Paid In Capital IncreaseInDebtDiscountAndAdditionalPaidInCapital		usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo		usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2024Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
	SPAI	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Issued SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueIssued		usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	110000	usd
CY2024Q2	SPAI	Convertible Note Payable Current ConvertibleNotePayableCurrent	631001	usd
CY2023Q4	SPAI	Convertible Note Payable Current ConvertibleNotePayableCurrent	343796	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	73634	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	68522	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2279352	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1416729	usd
CY2024Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	146000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	146000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	61688	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	91112	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	207688	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	237112	usd
CY2024Q2	us-gaap	Liabilities Liabilities	2487040	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1653841	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9117583	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9117583	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8734770	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8734770	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	911	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	873	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9710913	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8597147	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9181073	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6822290	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	531379	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1776358	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3018419	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3430199	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	103008	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	950642	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	476515	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	69224	usd
	us-gaap	Cost Of Revenue CostOfRevenue	638812	usd
	us-gaap	Cost Of Revenue CostOfRevenue	305795	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	33784	usd
	us-gaap	Gross Profit GrossProfit	311830	usd
	us-gaap	Gross Profit GrossProfit	170720	usd
CY2023Q2	us-gaap	Salaries And Wages SalariesAndWages	317611	usd
	us-gaap	Salaries And Wages SalariesAndWages	829476	usd
	us-gaap	Salaries And Wages SalariesAndWages	572327	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	130474	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	85937	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	152432	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	175548	usd
	us-gaap	Professional Fees ProfessionalFees	1078210	usd
	us-gaap	Professional Fees ProfessionalFees	366490	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	94959	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	434712	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	200873	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	45529	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	91186	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	91057	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	764121	usd
	us-gaap	Operating Expenses OperatingExpenses	2519521	usd
	us-gaap	Operating Expenses OperatingExpenses	1383179	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-730337	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2207691	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1212459	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	505	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1151	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	151092	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2520	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1151	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-151092	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2015	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-731488	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2358783	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1214474	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8900762	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8900762	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7882501	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7882501	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8840294	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8840294	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7733642	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7733642	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1776358	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	548000	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	76802	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	489002	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2358783	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	531379	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2580775	usd
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	545625	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	58200	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	393000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	55000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1214474	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2418126	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	807300	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	450000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	489002	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1214923	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	531379	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2698414	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2698414	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	58200	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	393000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-731488	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2418126	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2418126	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2358783	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1214474	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	123054	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	118558	usd
	SPAI	Share Based Compensation And Professional Fees ShareBasedCompensationAndProfessionalFees	548000	usd
	SPAI	Share Based Compensation And Professional Fees ShareBasedCompensationAndProfessionalFees	113200	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	89006	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	-9584	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1398	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-121954	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	226106	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5413	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-50842	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	146449	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-44874	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	58207	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	40415	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	83157	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-24288	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-7257	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-43978	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	344633	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-30814	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1159475	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1170373	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	50913	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	172596	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-223509	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	275001	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	393000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	110000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	489002	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	18434	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	309619	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	855569	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	83381	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-527415	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1086992	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	703368	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1752266	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	175953	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	665274	usd
	us-gaap	Interest Paid Net InterestPaidNet	4562	usd
	us-gaap	Interest Paid Net InterestPaidNet	7120	usd
	SPAI	Increase In Intangible Assets And Equity For Asset Acquisition IncreaseInIntangibleAssetsAndEquityForAssetAcquisition	545625	usd
	SPAI	Increase In Debt Discount And Additional Paid In Capital IncreaseInDebtDiscountAndAdditionalPaidInCapital	76802	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2358783	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1159475	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9181073	usd
CY2024Q2	SPAI	Working Capital Deficit WorkingCapitalDeficit	1502950	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zkg7l0WKwaX7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span><span id="xdx_861_zGNpQyTBklM4">Use of estimates</span></span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates during the three months ended June 30, 2024 and 2023, include estimates for allowance for credit losses on accounts receivable and other receivables, estimates for obsolete or slow-moving inventory, the useful life of property and equipment, the valuation of assets acquired in an asset acquisition, the valuation of intangible assets and goodwill to determine any impairment, the estimate of the fair value of lease liabilities and related right of use assets, assumptions used in assessing impairment of long-lived assets, estimates related to the allocation of the transaction price for revenue recognition purposes, estimates of current and deferred income taxes and deferred tax valuation allowances, and the fair value of non-cash equity transactions.</span></p>
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	0	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	338739	usd
CY2024Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	250000	usd
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	172596	usd
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	0	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.80	pure
	us-gaap	Revenue Performance Obligation Description Of Good Or Service RevenuePerformanceObligationDescriptionOfGoodOrService	The remaining 20% of the contract price shall be authorized and received after 1) post-shipment inspection is performed, functionality testing is performed, and approval of the testing is granted. The 20% is triggered after testing and training. Local training with the contracted items consists of 1) use and care training, 2) engineering, repair, & maintenance, and 3) inventory management. Historically, the remaining 20% has not been collected. Although the Company believes this 20% will ultimately be collected, due to the historical non-payment of this 20%, the Company will not record such revenue until such time as collection is probable and all training and inspections are completed (See Note 11 – Commitments regarding this revenue stream).
	us-gaap	Other Expenses OtherExpenses	0	usd
	us-gaap	Other Expenses OtherExpenses	30788	usd
CY2024Q2	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	52988	usd
CY2023Q4	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	70555	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	77413	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	84670	usd
CY2024Q2	us-gaap	Advertising Expense AdvertisingExpense	16953	usd
	us-gaap	Advertising Expense AdvertisingExpense	30598	usd
CY2023Q2	us-gaap	Advertising Expense AdvertisingExpense	2795	usd
	us-gaap	Advertising Expense AdvertisingExpense	4267	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3894144	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4696251	shares
CY2024Q2	us-gaap	Share Price SharePrice	5.00
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	41375	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	163329	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	41375	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	163329	usd
CY2024Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024Q2	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	142526	usd
CY2023Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	142526	usd
CY2024Q2	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	142526	usd
CY2023Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	142526	usd
CY2024Q2	SPAI	Performance Guarantee Percentage PerformanceGuaranteePercentage	0.10	pure
CY2024Q2	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	142526	usd
CY2023Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	142526	usd
CY2024Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	269398	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	253737	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	88054	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	93532	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7120	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11890	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	364572	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	359159	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	459873	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	408960	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	120704	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	88032	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	339169	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	320928	usd
CY2024Q2	us-gaap	Depreciation Depreciation	17228	usd
	us-gaap	Depreciation Depreciation	32671	usd
CY2023Q2	us-gaap	Depreciation Depreciation	14046	usd
	us-gaap	Depreciation Depreciation	28092	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P3Y
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1416221	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-346716	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1069505	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1243625	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-256333	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	987292	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	45150	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	90383	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	45233	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	90466	usd
CY2024Q2	us-gaap	Goodwill Goodwill	684867	usd
CY2023Q4	us-gaap	Goodwill Goodwill	684867	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	420340	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	321890	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	317007	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	10268	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1069505	usd
CY2024Q2	us-gaap	Notes Payable To Bank NotesPayableToBank	256000	usd
CY2023Q4	us-gaap	Notes Payable To Bank NotesPayableToBank	146000	usd
CY2024Q2	us-gaap	Notes Payable NotesPayable	256000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	146000	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	110000	usd
CY2024Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	146000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	146000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	110000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	4129	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	3280	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	3405	usd
CY2024Q2	SPAI	Long Term Debt Maturities Repayments Of Principal In Year Six LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix	3535	usd
CY2024Q2	SPAI	Long Term Debt Maturities Repayments Of Principal After Year Six LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearSix	131651	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	256000	usd
CY2024Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	52222	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	89006	usd
CY2024Q2	SPAI	Convertible Notes Payable Gross ConvertibleNotesPayableGross	750001	usd
CY2023Q4	SPAI	Convertible Notes Payable Gross ConvertibleNotesPayableGross	475000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	119000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	131204	usd
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	631001	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	343796	usd
CY2024Q2	SPAI	Convertible Note Payable Current ConvertibleNotePayableCurrent	631001	usd
CY2023Q4	SPAI	Convertible Note Payable Current ConvertibleNotePayableCurrent	343796	usd
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	314141	shares
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	148438	shares
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	3.20
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	3.20
CY2024Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	5.00
CY2024Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	5.00
CY2024Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	50000	shares
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	98000	usd
CY2024Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.96
CY2024Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	180000	shares
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	450000	usd
CY2024Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.50
CY2024Q2	SPAI	Share Based Compensation And Professional Fees ShareBasedCompensationAndProfessionalFees	450000	usd
	SPAI	Share Based Compensation And Professional Fees ShareBasedCompensationAndProfessionalFees	548000	usd
CY2023Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	30000	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	30000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	58200	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	58200	usd
CY2023Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.94
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	545625	usd
CY2023Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.94
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	611017	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.00
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y6M
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	574356	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	238751	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.94
	SPAI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1	P2Y9M18D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	849768	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.26
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y2M12D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	1051211	usd
CY2024Q2	SPAI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisable	849768	shares
CY2024Q2	SPAI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateExercisable	1.26
	SPAI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms2 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms2	P2Y2M12D
CY2024Q2	SPAI	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable	1051211	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue	2.50
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue	1.94
	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	450000	shares
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	500000	shares
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1000000	usd
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	0	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	338739	usd
CY2024Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	250000	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	298361	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	793458	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	93003	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	814892	usd
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P36M
CY2022Q3	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-07-31
	us-gaap	Payments For Rent PaymentsForRent	2704	usd
CY2022Q3	SPAI	Percentage Of Annual Escalation Of Base Rent PercentageOfAnnualEscalationOfBaseRent	0.04	pure
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	92509	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	92509	usd
CY2021Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P62M
CY2021Q3	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2026-09-30
	us-gaap	Payments For Rent PaymentsForRent	3043	usd
CY2021Q3	SPAI	Percentage Of Annual Escalation Of Base Rent PercentageOfAnnualEscalationOfBaseRent	0.04	pure
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	154265	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	156963	usd
CY2024Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P39M
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19583	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	9835	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0375	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2024Q2	SPAI	Office Lease Right Of Use Assets OfficeLeaseRightOfUseAssets	266357	usd
CY2023Q4	SPAI	Office Lease Right Of Use Assets OfficeLeaseRightOfUseAssets	246774	usd
CY2024Q2	SPAI	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	-127681	usd
CY2023Q4	SPAI	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	-93370	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	138676	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	153404	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	135322	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	159634	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	73634	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	68522	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	61688	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	91112	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	79218	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	48787	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	13639	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	141644	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6322	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	135322	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	642989	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	103008	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	950642	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	476515	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	62378	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	59280	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	123054	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	118558	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	92117	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1151	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	151092	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2520	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1214923	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-731488	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2358783	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1214474	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	339169	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	320928	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-038306-index-headers.html	Edgar Link	pending
0001493152-24-038306-index.html	Edgar Link	pending
0001493152-24-038306.txt	Edgar Link	pending
0001493152-24-038306-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
spai-20240630.xsd	Edgar Link	pending
spai-20240630_cal.xml	Edgar Link	unprocessable
spai-20240630_def.xml	Edgar Link	unprocessable
spai-20240630_lab.xml	Edgar Link	unprocessable
spai-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SPAI
Safe Pro Group Inc Stock $spai

2024 Q3 Form 10-Q Financial Statement

#000149315224038306 Filed on September 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SPAI Safe Pro Group Inc Stock $spai

2024 Q3 Form 10-Q Financial Statement

#000149315224038306 Filed on September 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SPAI
Safe Pro Group Inc Stock $spai